US Patent Issued to ABBISKO THERAPEUTICS on Aug. 11 for "FGFR and mutation inhibitor thereof, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,703, issued on Aug. 11, was assigned to ABBISKO THERAPEUTICS Co. LTD. (Shanghai).

"FGFR and mutation inhibitor thereof, preparation method therefor and use thereof" was invented by Haibing Deng (Shanghai), Haiyan Ying (Shanghai), Hongping Yu (Shanghai), Zhui Chen (Shanghai) and Yaochang Xu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an FGFR and a mutation inhibitor thereof, and a preparation method therefor and the use thereof. In particular, provided are an FGFR having a structure of formula (I) and a mutation inhibitor thereof, a preparation method therefor, a pharmaceutical composition containing same, the use thereof as...